ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
World Health Organization, 2007. Fascioliasis: Infection with the “Neglected” Neglected Worms. Available at: http://www.who.int/neglected_diseases/integrated_media/integrated_media_fascioliasis/en. Accessed March 18, 2014.
-
2.
Mas-Coma S, Valero MA, Bargues MD, 2009. Chapter 2: Fasciola, lymnaeids, and human fascioliasis, with a global overview of disease transmission, epidemiology, evolutionary genetics, molecular epidemiology, and control. Adv Parasitol 69: 41–146.
-
3.
Cabada MM, White AC Jr, 2012. New developments in the epidemiology, diagnosis, and treatment of fascioliasis. Curr Opin Infect Dis 25: 518–522.
-
4.
Marcos LA, Maco V, Florencio L, Terashima A, Samalvides F, Espinoza JR, Miranda E, Tantaleán M, Gotuzzo E, 2005. Altas tasas de prevalencia de fasciolosis humana en el Peru: una enfermedad emergente. Rev Peru Enferm Infecc Trop 3: 8–13.
-
5.
Parkinson M, O'Neill SM, Dalton JP, 2006. Endemic human fasciolosis in the Bolivian Altiplano. Epidemiol Infect 26: 1–6.
-
6.
Marcos LA, Maco V, Terashima A, Samalvides F, Gotuzzo E, 2002. Caracteristicas clínicas de la infección crónica por Fasciola hepatica en niños. Rev Gastroenterol Peru 22: 228–233.
-
7.
Marcos LA, Maco V, Castillo M, Terashima A, Serpa R, Gotuzzo E, 2005. Reporte de casos de fasciolasis en el Instituto Especializado de Salud del Nino, Lima-Peru (1988–2003). Rev Gastroenterol Peru 25: 198–205.
-
8.
El-Shazly AM, El-Nahas HA, Abdel-Mageed AA, El Beshbishi SN, Azab MS, Abou El Hasan M, Arafa WA, Morsy TA, 2005. Human fascioliasis and anaemia in Dakahlia governorate, Egypt. J Egypt Soc Parasitol 35: 421–432.
-
9.
Lopez M, White AC, Cabada MM, 2012. Burden of Fasciola hepatica infection among children from Paucartambo in Cuzco, Peru. Am J Trop Med Hyg 86: 481–485.
-
10.
Karahocagil MK, Akdeniz H, Sunnetcioglu M, Cicek M, Mete R, Akman N, Ceylan E, Karsen H, Yapici K, 2011. A familial outbreak of fascioliasis in eastern Anatolia: a report with review of literature. Acta Trop 118: 177–183.
-
11.
Marcos LA, Terashima A, Leguia G, Canales M, Espinoza JR, Gotuzzo E, 2007. La infeccion por Fasciola hepatica en el Peru: una enfermedad emergente. Rev Gastroenterol Peru 27: 389–396.
-
12.
Mas-Coma S, 2005. Epidemiology of fascioliasis in human endemic areas. J Helminthol 79: 207–216.
-
13.
Marcos L, Maco V, Samalvides F, Terashima A, Espinoza JR, Gotuzzo E, 2006. Risk factors for Fasciola hepatica infection in children: a case-control study. Trans R Soc Trop Med Hyg 100: 158–166.
-
14.
Zumaquero-Rıos JL, Sarracent-Perez J, Rojas-Garcıa R, Rojas-Rivero L, Martınez-Tovilla Y, Valero MA, Mas-Coma S, 2013. Fascioliasis and intestinal parasitoses affecting schoolchildren in Atlixco, Puebla State, Mexico: epidemiology and treatment with nitazoxanide. PLoS Negl Trop Dis 7: e2553.
-
15.
Maco-Flores V, Marcos-Raymundo L, Terashima-Iwashita A, Samalbvides-Cuba F, Miranda-Sanchez E, Espinoza-Babilon J, Gotuzzo-Herencia J, 2002. Fas-2 ELISA and the Rapid Sedimentation Technique Modified by Lumbreras for Fasciola Hepatica Infection Diagnosis. Available at: http://www.scielo.org.pe/pdf/rmh/v13n2/v13n2ao3.pdf. Accessed March 18, 2014.
-
16.
Lozoff B, Beard J, Connor J, Barbara F, Georgieff M, Schallert T, 2006. Long-lasting neural and behavioral effects of iron deficiency in infancy. Nutr Rev 64 (Suppl 2): S34–S43.
-
17.
World Health Organization, 2013. Fascioliasis Diagnosis, Treatment and Control Strategy. Available at: http://www.who.int/foodborne_trematode_infections/fascioliasis/fascioliasis_diagnosis/en/index.html. Accessed March 11, 2014.
-
18.
Villegas F, Angles R, Barrientos R, Barrios G, Valero MA, Hamed K, Grueninger H, Ault SK, Montresor A, Engels D, Mas-Coma S, Gabrielli AF, 2012. Administration of triclabendazole is safe and effective in controlling fascioliasis in an endemic community of the Bolivian Altiplano. PLoS Negl Trop Dis 76: e1720.
-
19.
Taylor-Robinson DC, Maayan N, Soares-Weiser K, Donegan S, Garner P, 2012. Deworming drugs for soil-transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin and school performance. Cochrane Database Syst Rev 11: CD000371.
-
20.
Awasthi S, Peto R, Read S, Richards SM, Pande V, Bundy D; DEVTA (Deworming and Enhanced Vitamin A) Team, 2013. Population deworming every 6 months with albendazole in 1 million pre-school children in north India: DEVTA, a cluster-randomized trial. Lancet 381: 1478–1486.
-
21.
Esteban JG, Gonzalez C, Bargues MD, Angles R, Sánchez C, Náquira C, Mas-Coma S, 2002. High fascioliasis infection in children linked to a man-made irrigation zone in Peru. Trop Med Int Health 7: 339–348.
-
22.
Esteban JG, Flores A, Aguirre C, Strauss W, Angles R, Mas-Coma S, 1997. Presence of very high prevalence and intensity of infection with Fasciola hepatica among Aymara children from the northern Bolivian Altiplano. Acta Trop 66: 1–14.
-
23.
Heukelbach J, Poggensee G, Winter B, Wilcke T, Kerr-Pontes LR, Feldmeier H, 2006. Leukocytosis and blood eosinophilia in a polyparasitised population in north-eastern Brazil. Trans R Soc Trop Med Hyg 100: 32–40.
-
24.
Fica A, Dabanch J, Farias C, Castro M, Jercic MI, Weitzel T, 2012. Acute fascioliasis—clinical and epidemiological features of four patients in Chile. Clin Microbiol Infect 18: 91–96.
-
25.
Kaya M, Beştaş R, Çetin S, 2011. Clinical presentation and management of Fasciola hepatica infection: single-center experience. World J Gastroenterol 17: 4899–4904.
-
26.
Esteban JG, Flores A, Angles R, Mas-Coma S, 1999. High endemicity of human fascioliasis between Lake Titicaca and La Paz valley, Bolivia. Trans R Soc Trop Med Hyg 93: 151–156.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 989 | 888 | 62 |
| Full Text Views | 414 | 14 | 0 |
| PDF Downloads | 134 | 14 | 0 |
Fascioliasis and Eosinophilia in the Highlands of Cuzco, Peru and Their Association with Water and Socioeconomic Factors
Miguel M. Cabada
Miguel M. Cabada
Universidad Peruana Cayetano Heredia and University of Texas Medical Branch Collaborative Research Center–Cuzco, Cuzco, Peru; Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas
Search for other papers by Miguel M. Cabada in
Current site
Google Scholar
PubMed
Search for other papers by Miguel M. Cabada in
Current site
Google Scholar
PubMed
Mary R. Goodrich
Mary R. Goodrich
Universidad Peruana Cayetano Heredia and University of Texas Medical Branch Collaborative Research Center–Cuzco, Cuzco, Peru; Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas
Search for other papers by Mary R. Goodrich in
Current site
Google Scholar
PubMed
Search for other papers by Mary R. Goodrich in
Current site
Google Scholar
PubMed
Brittany Graham
Brittany Graham
Universidad Peruana Cayetano Heredia and University of Texas Medical Branch Collaborative Research Center–Cuzco, Cuzco, Peru; Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas
Search for other papers by Brittany Graham in
Current site
Google Scholar
PubMed
Search for other papers by Brittany Graham in
Current site
Google Scholar
PubMed
Pablo G. Villanueva-Meyer
Pablo G. Villanueva-Meyer
Universidad Peruana Cayetano Heredia and University of Texas Medical Branch Collaborative Research Center–Cuzco, Cuzco, Peru; Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas
Search for other papers by Pablo G. Villanueva-Meyer in
Current site
Google Scholar
PubMed
Search for other papers by Pablo G. Villanueva-Meyer in
Current site
Google Scholar
PubMed
Martha Lopez
Martha Lopez
Universidad Peruana Cayetano Heredia and University of Texas Medical Branch Collaborative Research Center–Cuzco, Cuzco, Peru; Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas
Search for other papers by Martha Lopez in
Current site
Google Scholar
PubMed
Search for other papers by Martha Lopez in
Current site
Google Scholar
PubMed
Eulogia Arque
Eulogia Arque
Universidad Peruana Cayetano Heredia and University of Texas Medical Branch Collaborative Research Center–Cuzco, Cuzco, Peru; Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas
Search for other papers by Eulogia Arque in
Current site
Google Scholar
PubMed
Search for other papers by Eulogia Arque in
Current site
Google Scholar
PubMed
A. Clinton White Jr.
A. Clinton White Jr.
Universidad Peruana Cayetano Heredia and University of Texas Medical Branch Collaborative Research Center–Cuzco, Cuzco, Peru; Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas
Search for other papers by A. Clinton White Jr. in
Current site
Google Scholar
PubMed
Search for other papers by A. Clinton White Jr. in
Current site
Google Scholar
PubMed
There are limited data about the epidemiology of fascioliasis in Cuzco, Peru. We studied children 3–12 years old from six communities in the highlands of Cuzco to evaluate the epidemiology of fascioliasis; 227 children were included, one-half were female, the mean age was 7.5 (±2.6) years, and 46.2±% had one or more parasites, including Fasciola (9.7%), Ascaris (12.8%), Hymenolepis (9.3%), Trichuris (1.3%), hookworm (1.8%), Strongyloides (0.9%), and Giardia (27.8%). Fasciola was associated with the number of siblings in the household, drinking untreated water, and giardiasis. Eosinophilia was encountered in 21% of children and more common in those drinking untreated water at home and those infected with a parasite, but the differences were not significant. Eating water plants was not associated with Fasciola or eosinophilia. Fascioliasis and eosinophilia were common in the highlands of Cuzco. Fascioliasis was associated with socioeconomic factors and drinking water.
Author Notes
Financial support: This study was supported, in part, by National Institute for Allergies and Infectious Disease at the National Institutes of Health Grant 1R01AI104820-01.
Authors' addresses: Miguel M. Cabada, Universidad Peruana Cayetano Heredia and University of Texas Medical Branch Collaborative Research Center–Cuzco, Cuzco, Peru, and Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, E-mail: micabada@utmb.edu. Mary R. Goodrich, Brittany Graham, Pablo G. Villanueva-Meyer, and A. Clinton White Jr., School of Medicine, University of Texas Medical Branch, Galveston, TX, E-mails: mrgoodri@utmb.edu, bmgraham@utmb.edu, pevillan@utmb.edu, and acwhite@utmb.edu. Martha Lopez and Eulogia Arque, UPCH-UTMB Collaborative Research Center–Cuzco, Cuzco, Peru, E-mails: martlop2000@gmail.com and picis_11_90@hotmail.com.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
World Health Organization, 2007. Fascioliasis: Infection with the “Neglected” Neglected Worms. Available at: http://www.who.int/neglected_diseases/integrated_media/integrated_media_fascioliasis/en. Accessed March 18, 2014.
-
2.
Mas-Coma S, Valero MA, Bargues MD, 2009. Chapter 2: Fasciola, lymnaeids, and human fascioliasis, with a global overview of disease transmission, epidemiology, evolutionary genetics, molecular epidemiology, and control. Adv Parasitol 69: 41–146.
-
3.
Cabada MM, White AC Jr, 2012. New developments in the epidemiology, diagnosis, and treatment of fascioliasis. Curr Opin Infect Dis 25: 518–522.
-
4.
Marcos LA, Maco V, Florencio L, Terashima A, Samalvides F, Espinoza JR, Miranda E, Tantaleán M, Gotuzzo E, 2005. Altas tasas de prevalencia de fasciolosis humana en el Peru: una enfermedad emergente. Rev Peru Enferm Infecc Trop 3: 8–13.
-
5.
Parkinson M, O'Neill SM, Dalton JP, 2006. Endemic human fasciolosis in the Bolivian Altiplano. Epidemiol Infect 26: 1–6.
-
6.
Marcos LA, Maco V, Terashima A, Samalvides F, Gotuzzo E, 2002. Caracteristicas clínicas de la infección crónica por Fasciola hepatica en niños. Rev Gastroenterol Peru 22: 228–233.
-
7.
Marcos LA, Maco V, Castillo M, Terashima A, Serpa R, Gotuzzo E, 2005. Reporte de casos de fasciolasis en el Instituto Especializado de Salud del Nino, Lima-Peru (1988–2003). Rev Gastroenterol Peru 25: 198–205.
-
8.
El-Shazly AM, El-Nahas HA, Abdel-Mageed AA, El Beshbishi SN, Azab MS, Abou El Hasan M, Arafa WA, Morsy TA, 2005. Human fascioliasis and anaemia in Dakahlia governorate, Egypt. J Egypt Soc Parasitol 35: 421–432.
-
9.
Lopez M, White AC, Cabada MM, 2012. Burden of Fasciola hepatica infection among children from Paucartambo in Cuzco, Peru. Am J Trop Med Hyg 86: 481–485.
-
10.
Karahocagil MK, Akdeniz H, Sunnetcioglu M, Cicek M, Mete R, Akman N, Ceylan E, Karsen H, Yapici K, 2011. A familial outbreak of fascioliasis in eastern Anatolia: a report with review of literature. Acta Trop 118: 177–183.
-
11.
Marcos LA, Terashima A, Leguia G, Canales M, Espinoza JR, Gotuzzo E, 2007. La infeccion por Fasciola hepatica en el Peru: una enfermedad emergente. Rev Gastroenterol Peru 27: 389–396.
-
12.
Mas-Coma S, 2005. Epidemiology of fascioliasis in human endemic areas. J Helminthol 79: 207–216.
-
13.
Marcos L, Maco V, Samalvides F, Terashima A, Espinoza JR, Gotuzzo E, 2006. Risk factors for Fasciola hepatica infection in children: a case-control study. Trans R Soc Trop Med Hyg 100: 158–166.
-
14.
Zumaquero-Rıos JL, Sarracent-Perez J, Rojas-Garcıa R, Rojas-Rivero L, Martınez-Tovilla Y, Valero MA, Mas-Coma S, 2013. Fascioliasis and intestinal parasitoses affecting schoolchildren in Atlixco, Puebla State, Mexico: epidemiology and treatment with nitazoxanide. PLoS Negl Trop Dis 7: e2553.
-
15.
Maco-Flores V, Marcos-Raymundo L, Terashima-Iwashita A, Samalbvides-Cuba F, Miranda-Sanchez E, Espinoza-Babilon J, Gotuzzo-Herencia J, 2002. Fas-2 ELISA and the Rapid Sedimentation Technique Modified by Lumbreras for Fasciola Hepatica Infection Diagnosis. Available at: http://www.scielo.org.pe/pdf/rmh/v13n2/v13n2ao3.pdf. Accessed March 18, 2014.
-
16.
Lozoff B, Beard J, Connor J, Barbara F, Georgieff M, Schallert T, 2006. Long-lasting neural and behavioral effects of iron deficiency in infancy. Nutr Rev 64 (Suppl 2): S34–S43.
-
17.
World Health Organization, 2013. Fascioliasis Diagnosis, Treatment and Control Strategy. Available at: http://www.who.int/foodborne_trematode_infections/fascioliasis/fascioliasis_diagnosis/en/index.html. Accessed March 11, 2014.
-
18.
Villegas F, Angles R, Barrientos R, Barrios G, Valero MA, Hamed K, Grueninger H, Ault SK, Montresor A, Engels D, Mas-Coma S, Gabrielli AF, 2012. Administration of triclabendazole is safe and effective in controlling fascioliasis in an endemic community of the Bolivian Altiplano. PLoS Negl Trop Dis 76: e1720.
-
19.
Taylor-Robinson DC, Maayan N, Soares-Weiser K, Donegan S, Garner P, 2012. Deworming drugs for soil-transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin and school performance. Cochrane Database Syst Rev 11: CD000371.
-
20.
Awasthi S, Peto R, Read S, Richards SM, Pande V, Bundy D; DEVTA (Deworming and Enhanced Vitamin A) Team, 2013. Population deworming every 6 months with albendazole in 1 million pre-school children in north India: DEVTA, a cluster-randomized trial. Lancet 381: 1478–1486.
-
21.
Esteban JG, Gonzalez C, Bargues MD, Angles R, Sánchez C, Náquira C, Mas-Coma S, 2002. High fascioliasis infection in children linked to a man-made irrigation zone in Peru. Trop Med Int Health 7: 339–348.
-
22.
Esteban JG, Flores A, Aguirre C, Strauss W, Angles R, Mas-Coma S, 1997. Presence of very high prevalence and intensity of infection with Fasciola hepatica among Aymara children from the northern Bolivian Altiplano. Acta Trop 66: 1–14.
-
23.
Heukelbach J, Poggensee G, Winter B, Wilcke T, Kerr-Pontes LR, Feldmeier H, 2006. Leukocytosis and blood eosinophilia in a polyparasitised population in north-eastern Brazil. Trans R Soc Trop Med Hyg 100: 32–40.
-
24.
Fica A, Dabanch J, Farias C, Castro M, Jercic MI, Weitzel T, 2012. Acute fascioliasis—clinical and epidemiological features of four patients in Chile. Clin Microbiol Infect 18: 91–96.
-
25.
Kaya M, Beştaş R, Çetin S, 2011. Clinical presentation and management of Fasciola hepatica infection: single-center experience. World J Gastroenterol 17: 4899–4904.
-
26.
Esteban JG, Flores A, Angles R, Mas-Coma S, 1999. High endemicity of human fascioliasis between Lake Titicaca and La Paz valley, Bolivia. Trans R Soc Trop Med Hyg 93: 151–156.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 989 | 888 | 62 |
| Full Text Views | 414 | 14 | 0 |
| PDF Downloads | 134 | 14 | 0 |